alanine has been researched along with aspirin in 40 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (7.50) | 18.7374 |
| 1990's | 3 (7.50) | 18.2507 |
| 2000's | 19 (47.50) | 29.6817 |
| 2010's | 12 (30.00) | 24.3611 |
| 2020's | 3 (7.50) | 2.80 |
| Authors | Studies |
|---|---|
| Arvanitakis, C; Bornstein, J; Cooke, HJ; Folscroft, J | 1 |
| DeWitt, DL; Kraemer, SA; Meade, EA; Shimokawa, T; Smith, WL | 1 |
| De Weck, AL; Geczy, AF | 1 |
| Giugliano, D; Lefebvre, PJ; Luyckx, AS | 1 |
| Abdel-Wahab, YH; Barnett, CR; Flatt, PR; O'Harte, FP | 1 |
| Ferguson, JJ | 1 |
| Goepel, E; Niemax, K; Rybakowski, C; Schröder, HJ | 1 |
| Asai, F; Naganuma, H; Ogawa, T; Sugidachi, A | 1 |
| Alexander, JC; Anders, RJ; Berink, P; Braunwald, E; Cannon, CP; Caspi, A; Charlesworth, A; Langer, A; Lopez-Sendon, J; McCabe, CH; Skene, A; Toman, J; Wilcox, RG | 1 |
| McGuire, DK; Newby, LK | 1 |
| Bozarth, J; Confalone, PN; Forsythe, M; Jin, F; Mousa, SA | 1 |
| Bhatt, DL; Chew, DP; Sapp, S; Topol, EJ | 1 |
| Braunwald, E; Cannon, CP; Fitzgerald, A; Fitzgerald, DJ; O'Connor, FF; Shields, DC | 1 |
| Barbera, FA; Dorsam, RT; Feuerstein, GZ; Friedman, SM; Gibbs, S; Lauver, A; Savion, N; Varon, D; Wang, H; Wang, X | 1 |
| Halushka, MK; Halushka, PV; Walker, LP | 1 |
| Bentley, J; Blatt, A; Braunwald, E; Cannon, CP; Caspi, A; Charlesworth, A; Cotter, G; Kaluski, E; Krakover, R; Lewis, B; Marmor, A; McCabe, CH; Michowitz, Y; Milo, O; Reisin, L; Vered, Z; Zimlichman, R | 1 |
| Cannon, CP; Feske, SK; Murphy, S; Schwamm, LH; Smith, EE | 1 |
| Atar, S; Birnbaum, Y; Cannon, CP; Murphy, SA; Rosanio, S; Uretsky, BF | 1 |
| Aster, RH; Brassard, J; Braunwald, E; Cannon, CP; Charlesworth, A; Cooper, R; McCabe, CH; Scirica, BM; Skene, AM | 1 |
| Ahnen, DJ; Baron, JA; Barry, EL; Bhat, S; Burke, CA; Grau, MV; Haile, RW; O'Brien, TG; Sandler, RS | 1 |
| Alonso Castillejos, N; García Iglesias, R; Inglada-Galiana, L; Martín Gil, FJ; San Miguel Hernández, A | 1 |
| Handa, O; Ichikawa, H; Isozaki, Y; Kajikawa, H; Kokura, S; Matsui, H; Naito, Y; Nakabe, N; Suzuki, T; Takagi, T; Yoshida, N; Yoshikawa, T | 1 |
| Goto, S; Kawai, T; Yamagishi, T | 1 |
| Asaka, M; Kamada, G; Kato, M; Nishida, M; Nishida, U; Ono, S; Shimizu, Y; Yoshida, T | 1 |
| Abe, T; Fujioka, T; Inoue, K; Kodama, M; Mizukami, K; Murakami, K; Okimoto, T; Uchida, M | 1 |
| Fujita, T; Kato, M; Katsuki, S; Kurokawa, S; Nishikawa, K; Ohira, K; Ohta, H; Saitoh, Y; Sato, Y; Yamada, M | 1 |
| Fukui, H; Hida, N; Hori, K; Miwa, H; Nakamura, S; Ogawa, T; Ohda, Y; Okugawa, T; Oshima, T; Tomita, T; Tozawa, K; Watari, J | 1 |
| Furuta, T; Sugimoto, M; Uotani, T | 1 |
| Bereta, G; Buda, A; Chomyszyn-Gajewska, M; Gawron, K; Koziel, J; Lazarz, M; Lazarz-Bartyzel, K; Mizgalska, D; Nowakowska, Z; Oruba, Z; Potempa, J; Szmigielski, B | 1 |
| Amagase, K; Hashimoto, E; Itayama, M; Izuhara, C; Takayama, S; Takeuchi, K | 1 |
| Arakawa, T; Fujimoto, K; Handa, O; Higuchi, K; Naito, Y; Sakata, Y; Shiba, M; Takeuchi, T; Tanigawa, T; Watanabe, T; Yoshikawa, T | 1 |
| Chen, QK; Lai, Y; Li, JY; Ouyang, H; Shan, TD; Xia, ZS; Yang, HS; Yu, T; Zhong, W | 1 |
| Chen, Z; Hu, L; Jiang, S; Lin, F; Song, H; Tong, S; Wen, C; Zhang, J; Zhang, X | 1 |
| Dohi, O; Fukui, A; Handa, O; Higashimura, Y; Ishikawa, T; Itoh, Y; Kamada, K; Katada, K; Konishi, H; Majima, A; Mukai, R; Naito, Y; Okayama, T; Suyama, Y; Takagi, T; Takayama, S; Uchiyama, K; Ushiroda, C; Yasuda-Onozawa, Y; Yoshida, N | 1 |
| Chaitongrat, S; Lertsuwunseri, V; Mahachai, V; Pittayanon, R; Piyachaturawat, P; Prueksapanich, P; Rerknimitr, R; Srimahachota, S | 1 |
| Chan, HL; Hui, VW; Lui, GC; Tse, YK; Wong, GL; Wong, VW; Yip, TC | 1 |
| Amini, H; Azhdari Tehrani, H; Haji Aghajani, M; Moradi, O; Pourheidar, E; Rabiei, MM; Sistanizad, M | 1 |
| Brandt, C; Deinhardt-Emmer, S; Doshi, H; Ehrhardt, C; Giebeler, L; Häring, C; Jungwirth, J; König, S; Löffler, B | 1 |
| Duffy, EM; Jorgensen, WL | 1 |
| Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
2 review(s) available for alanine and aspirin
| Article | Year |
|---|---|
Oral platelet glycoprotein IIb/IIIa inhibition.
Topics: Alanine; Angina, Unstable; Aspirin; Benzamidines; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Humans; Myocardial Infarction; Oximes; Piperidines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyrrolidines; Syndrome; Treatment Outcome | 2000 |
Increased mortality with oral platelet glycoprotein IIb/IIIa antagonists: a meta-analysis of phase III multicenter randomized trials.
Topics: Administration, Oral; Alanine; Aspirin; Benzamidines; Clinical Trials, Phase III as Topic; Coronary Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Hemorrhage; Humans; Incidence; Multicenter Studies as Topic; Myocardial Infarction; Oximes; Piperidines; Platelet Glycoprotein GPIIb-IIIa Complex; Pyrrolidines; Randomized Controlled Trials as Topic | 2001 |
12 trial(s) available for alanine and aspirin
| Article | Year |
|---|---|
Oral glycoprotein IIb/IIIa inhibition with orbofiban in patients with unstable coronary syndromes (OPUS-TIMI 16) trial.
Topics: Administration, Oral; Alanine; Anticoagulants; Aspirin; Coronary Disease; Double-Blind Method; Female; Follow-Up Studies; Heparin; Humans; Intracranial Hemorrhages; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyrrolidines; Stroke; Survival Analysis; Thrombocytopenia; Treatment Outcome | 2000 |
Genetic variation in glycoprotein IIb/IIIa (GPIIb/IIIa) as a determinant of the responses to an oral GPIIb/IIIa antagonist in patients with unstable coronary syndromes.
Topics: Aged; Alanine; Angina, Unstable; Antigens, Human Platelet; Aspirin; Double-Blind Method; Female; Genetic Variation; Genotype; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Placebos; Platelet Glycoprotein GPIIb-IIIa Complex; Polymorphism, Genetic; Pyrrolidines | 2001 |
Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: are we doing enough? Results from the Orbofiban in Patients with Unstable Coronary Syndromes-Thrombolysi
Topics: Aged; Alanine; Aspirin; Cerebrovascular Disorders; Coronary Disease; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Multivariate Analysis; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Pyrrolidines; Regression Analysis; Risk Factors; Treatment Outcome | 2003 |
Risk factors for stroke after acute coronary syndromes in the Orbofiban in Patients with Unstable Coronary Syndromes--Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 study.
Topics: Aged; Alanine; Angina, Unstable; Aspirin; Cerebral Hemorrhage; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Ischemic Attack, Transient; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Proportional Hazards Models; Pyrrolidines; Risk Factors; Stroke; Syndrome; Thrombolytic Therapy | 2006 |
Drug-induced thrombocytopenia and thrombosis: evidence from patients receiving an oral glycoprotein IIb/IIIa inhibitor in the Orbofiban in Patients with Unstable coronary Syndromes- (OPUS-TIMI 16) trial.
Topics: Aged; Alanine; Angina, Unstable; Aspirin; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyrrolidines; Thrombocytopenia; Thrombosis | 2006 |
Circadian variations of gastrointestinal mucosal damage detected with transnasal endoscopy in apparently healthy subjects treated with low-dose aspirin (ASA) for a short period.
Topics: Adult; Alanine; Aspirin; Circadian Rhythm; Double-Blind Method; Endoscopy; Female; Gastric Mucosa; Humans; Intestinal Mucosa; Male; Quinolones; Time Factors; Treatment Outcome; Ulcer; Young Adult | 2009 |
Evaluation of small bowel blood flow in healthy subjects receiving low-dose aspirin.
Topics: Adult; Alanine; Anti-Ulcer Agents; Area Under Curve; Aspirin; Blood Flow Velocity; Contrast Media; Cross-Over Studies; Double-Blind Method; Endoscopy; Humans; Intestine, Small; Male; Placebos; Quinolones; Treatment Outcome; Ultrasonography | 2011 |
Aspirin-induced small bowel injuries and the preventive effect of rebamipide.
Topics: Adult; Aged; Alanine; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Capsule Endoscopy; Cross-Over Studies; Double-Blind Method; Humans; Intestinal Diseases; Intestinal Mucosa; Intestine, Small; Male; Middle Aged; Omeprazole; Placebos; Quinolones; Young Adult | 2011 |
A randomized, double-blinded, placebo-controlled, multicenter trial, healing effect of rebamipide in patients with low-dose aspirin and/or non-steroidal anti-inflammatory drug induced small bowel injury.
Topics: Aged; Alanine; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Capsule Endoscopy; Dietary Proteins; Double-Blind Method; Female; Humans; Intestinal Diseases; Intestinal Mucosa; Intestine, Small; Male; Middle Aged; Quinolones; Wound Healing | 2014 |
A randomized, double-blind, placebo-controlled study of rebamipide for gastric mucosal injury taking aspirin with or without clopidogrel.
Topics: Adult; Alanine; Anti-Ulcer Agents; Aspirin; Clopidogrel; Double-Blind Method; Gastric Mucosa; Gastrointestinal Hemorrhage; Healthy Volunteers; Humans; Male; Peptic Ulcer; Platelet Aggregation Inhibitors; Quinolones; Ticlopidine; Young Adult | 2014 |
A multicenter, randomized, double-blind, placebo-controlled trial of high-dose rebamipide treatment for low-dose aspirin-induced moderate-to-severe small intestinal damage.
Topics: Aged; Alanine; Anti-Ulcer Agents; Aspirin; Capsule Endoscopy; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Intestinal Diseases; Intestine, Small; Male; Quinolones; Severity of Illness Index; Treatment Outcome | 2015 |
Cytoprotective agent for peptic ulcer prevention in patients taking dual antiplatelet agents: A randomized, double-blind placebo-controlled trial.
Topics: Aged; Alanine; Anti-Ulcer Agents; Aspirin; Cilostazol; Clopidogrel; Cytoprotection; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Peptic Ulcer; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Quinolones; Thailand; Ticagrelor; Time Factors; Treatment Outcome | 2019 |
26 other study(ies) available for alanine and aspirin
| Article | Year |
|---|---|
Effect of aspirin on sugar, amino acid, and sodium transport in rat jejunum.
Topics: Alanine; Amino Acids; Animals; Aspirin; Biological Transport, Active; Carbohydrate Metabolism; Jejunum; Male; Rats; Sodium | 1979 |
Molecular basis for the inhibition of prostanoid biosynthesis by nonsteroidal anti-inflammatory agents.
Topics: Acetylation; Alanine; Amino Acid Sequence; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclooxygenase Inhibitors; DNA; DNA Restriction Enzymes; Exons; Humans; Mice; Molecular Sequence Data; Mutagenesis, Site-Directed; Nucleic Acid Hybridization; Prostaglandin Antagonists; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Serine; Sheep | 1990 |
Histocompatibility antigens and genetic control of the immune response in guinea pigs. I. Specific inhibition of antigen-induced lymphocyte stimulation by alloantisera.
Topics: Alanine; Alleles; Animals; Antibodies; Antibody Formation; Aspirin; Cattle; Cells, Cultured; Cytotoxicity Tests, Immunologic; Dinitrophenols; Glycine; Guinea Pigs; Histocompatibility Antigens; Homozygote; Immune Sera; Immunity, Cellular; Immunization Schedule; Immunoglobulin G; Isoantibodies; Leucine; Lymph Nodes; Lymphocyte Activation; Lymphocytes; Lysine; Ovalbumin; Penicillins; Peptides; Peroxidases; Phenacetin; Skin Tests; Species Specificity | 1974 |
Effects of acetylsalicylic acid on blood glucose, plasma FFA, glycerol, 3-hydroxybutyrate, alanine, C-peptide, glucagon and growth hormone responses to arginine in insulin-dependent diabetics.
Topics: Adolescent; Adult; Alanine; Arginine; Aspirin; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Fatty Acids, Nonesterified; Female; Glucagon; Glycerol; Growth Hormone; Hormones; Humans; Hydroxybutyrates; Insulin; Male; Middle Aged | 1980 |
Glycation of insulin in a cultured insulin-secreting cell line.
Topics: Alanine; Animals; Ascorbic Acid; Aspirin; Cell Fusion; Cell Line; Chromatography, Affinity; Glucose; Glycosylation; Guanidines; Insulin; Insulin Secretion; Islets of Langerhans; Potassium; Rats | 1997 |
Meeting highlights. Highlights of the 48th scientific sessions of the American College of Cardiology.
Topics: Abciximab; Alanine; Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inhibitors; Antibodies, Monoclonal; Aspirin; Benzamidines; Biphenyl Compounds; Cardiology; Cardiovascular Agents; Clinical Trials as Topic; Clopidogrel; Combined Modality Therapy; Coronary Disease; Dalteparin; Defibrillators, Implantable; Double-Blind Method; Enalapril; Endothelial Growth Factors; Fatty Acids, Omega-3; Guanidines; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoglobulin Fab Fragments; Laser Therapy; Lymphokines; Metoprolol; Multicenter Studies as Topic; Myocardial Revascularization; Platelet Aggregation Inhibitors; Pyrrolidines; Randomized Controlled Trials as Topic; Simvastatin; Sodium-Hydrogen Exchangers; Stents; Sulfones; Thrombolytic Therapy; Ticlopidine; Tissue Plasminogen Activator; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Vitamin E | 1999 |
The effect of oxytocin, prostaglandin E2 and acetylsalicylic acid on flow distribution and on the transfer of alanine, glucose and water in isolated perfused guinea pig placentae.
Topics: Alanine; Animals; Aspirin; Biological Transport, Active; Dinoprostone; Female; Glucose; Guinea Pigs; In Vitro Techniques; Kinetics; Maternal-Fetal Exchange; Oxytocin; Perfusion; Placenta; Pregnancy; Water | 2000 |
Antiplatelet and antithrombotic effects of orbofiban, a new orally active GPIIb/IIIa antagonist, in guinea pigs.
Topics: Adenosine Diphosphate; Administration, Oral; Alanine; Animals; Arteriovenous Shunt, Surgical; Aspirin; beta-Alanine; Bleeding Time; Collagen; Disease Models, Animal; Dose-Response Relationship, Drug; Fibrinolytic Agents; Guinea Pigs; Hemostasis; Hypercholesterolemia; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyrrolidines; Thrombosis; Urea | 2000 |
Human platelet alphaIIbeta3 integrin binding affinity and specificity of SJ874: antiplatelet efficacy versus aspirin.
Topics: Alanine; Aspirin; Bacterial Proteins; Blood Platelets; Cell Adhesion; Cell Line; DNA-Binding Proteins; Epinephrine; Fibrinogen; Fibronectins; Humans; In Vitro Techniques; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex | 2000 |
Comparative analysis of various platelet glycoprotein IIb/IIIa antagonists on shear-induced platelet activation and adhesion.
Topics: Abciximab; Alanine; Amidines; Analysis of Variance; Antibodies, Monoclonal; Anticoagulants; Aspirin; Cell Aggregation; Dose-Response Relationship, Drug; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Isoxazoles; Peptides; Platelet Activation; Platelet Adhesiveness; Platelet Glycoprotein GPIIb-IIIa Complex; Pyrrolidines; Rheology; Shear Strength; Temperature; Tirofiban; Tyrosine | 2002 |
Genetic variation in cyclooxygenase 1: effects on response to aspirin.
Topics: Adult; Alanine; Aspirin; Blood Platelets; Blotting, Western; Cyclooxygenase 1; Cyclooxygenase Inhibitors; Cysteine; Dinoprost; DNA, Complementary; Ethanol; Female; Glycine; Humans; Isoenzymes; Male; Membrane Proteins; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Polymerase Chain Reaction; Polymorphism, Genetic; Prostaglandin-Endoperoxide Synthases; Radioimmunoassay; Reference Values; Sequence Analysis, DNA; Sex Characteristics; Threonine; Thromboxane B2 | 2003 |
Statins are associated with lower risk of gastrointestinal bleeding in patients with unstable coronary syndromes: analysis of the Orbofiban in Patients with Unstable coronary Syndromes-Thrombolysis In Myocardial Infarction 16 (OPUS-TIMI 16) trial.
Topics: Acute Disease; Administration, Oral; Aged; Alanine; Anticoagulants; Aspirin; Coronary Disease; Female; Gastrointestinal Hemorrhage; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Male; Middle Aged; Patient Discharge; Platelet Glycoprotein GPIIb-IIIa Complex; Pyrrolidines; Retrospective Studies; Risk Assessment; Severity of Illness Index; Syndrome | 2006 |
Ornithine decarboxylase polymorphism modification of response to aspirin treatment for colorectal adenoma prevention.
Topics: Adenoma; Adenomatous Polyposis Coli; Aged; Alanine; Anticarcinogenic Agents; Aspirin; Colorectal Neoplasms; Female; Folic Acid; Gastrointestinal Agents; Gene Frequency; Genotype; Glycine; Humans; Male; Middle Aged; Ornithine Decarboxylase; Polymorphism, Single Nucleotide; Racial Groups; Randomized Controlled Trials as Topic; Risk Assessment | 2006 |
[Soluble CD40 ligand: a potential marker of cardiovascular risk].
Topics: Abciximab; Acute Coronary Syndrome; Alanine; Angina, Unstable; Animals; Antibodies, Monoclonal; Anticoagulants; Aspirin; Atherosclerosis; Biomarkers; Cardiovascular Diseases; CD40 Ligand; Chromosomes, Human, X; Clinical Trials as Topic; Disease Models, Animal; Female; Fibrinolytic Agents; Humans; Immunoglobulin Fab Fragments; Mice; Platelet Activation; Platelet Aggregation Inhibitors; Prognosis; Pyrrolidines; Risk Factors; Thrombosis | 2007 |
Prophylactic effect of rebamipide on aspirin-induced gastric lesions and disruption of tight junctional protein zonula occludens-1 distribution.
Topics: Alanine; Animals; Anti-Ulcer Agents; Aspirin; Cell Line; Cytoprotection; Fluorescent Antibody Technique; Gastric Mucosa; Male; Membrane Proteins; Permeability; Phosphoproteins; Quinolones; Rats; Rats, Sprague-Dawley; Zonula Occludens-1 Protein | 2008 |
Does rebamipide prevent gastric mucosal injury in patients taking aspirin and clopidogrel?
Topics: Alanine; Anti-Ulcer Agents; Aspirin; Clopidogrel; Gastrointestinal Hemorrhage; Humans; Male; Platelet Aggregation Inhibitors; Quinolones; Ticlopidine | 2014 |
Peptidylarginine deiminase from Porphyromonas gingivalis contributes to infection of gingival fibroblasts and induction of prostaglandin E2 -signaling pathway.
Topics: Adhesins, Bacterial; Alanine; Aspirin; Bacterial Adhesion; Cells, Cultured; Cyclooxygenase 2; Cysteine; Cysteine Endopeptidases; Dinoprostone; Fibroblasts; Gene Knockout Techniques; Gingipain Cysteine Endopeptidases; Gingiva; Humans; Hydrolases; Immunoassay; Intramolecular Oxidoreductases; Mutation; Porphyromonas gingivalis; Prostaglandin-E Synthases; Protein-Arginine Deiminases; Real-Time Polymerase Chain Reaction; Signal Transduction | 2014 |
Effect of rebamipide on gastric bleeding and ulcerogenic responses induced by aspirin plus clopidogrel under stimulation of acid secretion in rats.
Topics: Alanine; Animals; Anti-Ulcer Agents; Aspirin; Clopidogrel; Disease Models, Animal; Gastric Acid; Gastric Mucosa; Gastrointestinal Hemorrhage; Male; Platelet Aggregation Inhibitors; Quinolones; Rats, Sprague-Dawley; Stomach Ulcer; Ticlopidine; Treatment Outcome | 2014 |
Rebamipide Promotes the Regeneration of Aspirin-Induced Small-Intestine Mucosal Injury through Accumulation of β-Catenin.
Topics: Alanine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; beta Catenin; Body Weight; Cell Division; Cyclooxygenase 2; Dinoprostone; Female; Intestinal Absorption; Intestinal Mucosa; Jejunum; Male; Membrane Proteins; Mice; Mice, Inbred BALB C; Permeability; Proto-Oncogene Proteins c-myc; Quinolones; Random Allocation; Regeneration; RNA, Messenger; Tight Junctions | 2015 |
Fisher Discrimination of Metabolic Changes in Rats Treated with Aspirin and Ibuprofen.
Topics: Acetoacetates; Alanine; Alanine Transaminase; Alkaline Phosphatase; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspartate Aminotransferases; Aspirin; Diagnostic Techniques and Procedures; Hydroxybutyrates; Ibuprofen; Male; Metabolomics; Rats, Sprague-Dawley | 2017 |
Mucus reduction promotes acetyl salicylic acid-induced small intestinal mucosal injury in rats.
Topics: Alanine; Animals; Aspirin; Intestinal Mucosa; Intestine, Small; Male; Mucus; Polysorbates; Protective Agents; Quinolones; Rats, Sprague-Dawley | 2018 |
Aspirin Reduces the Incidence of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Receiving Oral Nucleos(t)ide Analog.
Topics: Adult; Aged; Alanine; Antiviral Agents; Aspirin; Carcinoma, Hepatocellular; Drug Therapy, Combination; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Guanine; Hepatitis B, Chronic; Hong Kong; Humans; Incidence; Liver Neoplasms; Male; Middle Aged; Retrospective Studies; Tenofovir | 2021 |
Decreased in-hospital mortality associated with aspirin administration in hospitalized patients due to severe COVID-19.
Topics: Adenosine Monophosphate; Adult; Aged; Alanine; Antiviral Agents; Aspirin; Blood Platelets; Coronary Artery Disease; COVID-19; COVID-19 Drug Treatment; Diabetes Mellitus; Disseminated Intravascular Coagulation; Drug Combinations; Female; Hospital Mortality; Humans; Hypertension; Iran; Lopinavir; Lung; Male; Middle Aged; Platelet Aggregation Inhibitors; Pulmonary Embolism; Respiration, Artificial; Retrospective Studies; Ritonavir; SARS-CoV-2; Severity of Illness Index; Survival Analysis; Treatment Outcome | 2021 |
D,L-Lysine-Acetylsalicylate + Glycine (LASAG) Reduces SARS-CoV-2 Replication and Shows an Additive Effect with Remdesivir.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Aspirin; COVID-19 Drug Treatment; Glycine; Humans; Lysine; SARS-CoV-2 | 2022 |
Prediction of drug solubility from Monte Carlo simulations.
Topics: Monte Carlo Method; Pharmaceutical Preparations; Solubility | 2000 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |